fixed swr [RSABE / ABEL]

posted by martin  – Austria, 2013-03-29 15:07 (2967 d 05:31 ago) – Posting: # 10311
Views: 17,964

(edited by martin on 2013-03-29 15:23)

Hi Helmut !

Yep; your are totally right (should have done my homework first ;-)). what about defining the extent of scaling after interim analysis of the first stage data (CV estimated in 1st stage) within a group-sequential adaptive design?

Drawback: BUT what if the CV at interim is smaller than 0.3 ... :confused:

best regards

martin

Complete thread:

Activity
 Admin contact
21,460 posts in 4,486 threads, 1,511 registered users;
online 4 (0 registered, 4 guests [including 4 identified bots]).
Forum time: Thursday 21:38 CEST (Europe/Vienna)

Nothing in the world is more dangerous
than sincere ignorance
and conscientious stupidity.    Martin Luther King, Jr.

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5